EZH2 and colorectal carcinoma: Particularly, accumulated data verified that expression levels of EZH2 are positively correlated with CRC grades and negatively correlated with survival, and EZH2 inhibitors have been demonstrated to have therapeutic effects in CRC treatment (15).